Pines Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$429K Buy
10,043
+2,136
+27% +$116K 0.12% 150
2026
Q1
$496K Sell
7,907
-530
-6% -$42.4K 0.16% 129
2025
Q4
$804K Sell
8,437
-398
-5% -$39K 0.26% 94
2025
Q3
$863K Sell
8,835
-224
-2% -$23.2K 0.29% 88
2025
Q2
$945K Buy
9,059
+674
+8% +$68.2K 0.33% 77
2025
Q1
$760K Sell
8,385
-28
-0.3% -$2.82K 0.35% 73
2024
Q4
$798K Buy
+8,413
New +$741K 0.35% 71

Other funds holding BSX

Pines Wealth Management's BSX Position: Q2 2026 in Review

Pines Wealth Management increased its Boston Scientific (BSX) stake by 27% in Q2 2026, buying an estimated $116K and bringing the position to 10,043 shares worth $429K. The position accounts for 0.12% of the portfolio, ranked #150.

Pines Wealth Management first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $945K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Pines Wealth Management held 10,043 shares of Boston Scientific worth $429K as of Q2 2026.
  • Pines Wealth Management bought 2,136 Boston Scientific shares in Q2 2026, an estimated $116K.
  • Boston Scientific made up 0.12% of Pines Wealth Management's portfolio in Q2 2026, its #150 holding.
  • Pines Wealth Management first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Pines Wealth Management's Boston Scientific position peaked at $945K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Pines Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.